1.	Positron Emission Tomography Using Fluoromisonidazole F 18 and Fludeoxyglucose F 18 to Find Oxygen in Tumor Cells of Patients Undergoing Treatment for Newly Diagnosed Stage IB, Stage II, Stage III, or Stage IV Cervical Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Diagnostic Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2009-00257, UW IRB# 6143, CDR0000574114, UW-6143, N01CM37008, 7958, NCT00559377
2.	Evaluation of [18F]-FMISO for Non Operated Glioblastoma Phase: Phase II Type: Health services research Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: CHUBX2008/31, NCT00906893
3.	18F-Fluoromisonidazole and Fludeoxyglucose F 18 PET/CT Scans in Assessing Oxygen in Tumor Tissue of Patients With Soft Tissue Sarcoma Undergoing Chemotherapy With or Without Radiation Therapy Phase: Phase II Type: Biomarker/Laboratory analysis, Diagnostic Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2011-01442, N01CM37008, 6971, UW-8468, 8468, NCT01169350
4.	HYPONCO - Hypoxia in Brain Tumors Phase: Phase II Type: Biomarker/Laboratory analysis, Diagnostic Status: Completed Age: 18 to 70 Sponsor: Other Protocol IDs: 2009-015543-16, NCT01200134
5.	Hypoxia-positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With Chordomas Phase: No phase specified Type: Diagnostic, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: 07-162, NCT00713037